Yasmin, Yaz Lawsuit Filings Continue to Mount

|

The number of lawsuits over Yaz and Yasmin continue to increase nationwide, with thousands of complaints filed on behalf of women who suffered severe or life-threatening health problems from the popular birth control pills. 

According to an annual report (pdf) filed this week by Bayer, the drug maker had been served with about 6,850 complaints as of February 1, 2011. This includes Yaz lawsuits, Yasmin lawsuits, as well as some lawsuits over generic equivalents, known as Gianvi and Ocella.

All of the complaints involve similar allegations that Bayer failed to adequately research their birth control pills or warn that side effects of Yaz and Yasmin increase the risk of blood clots, stroke, pulmonary embolism, deep vein thrombosis, gallbladder disease or other potentially fatal injuries.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The increased risk of Yaz and Yasmin health problems appears to be linked to the use of drospirenone, a fourth generation progestin that is only found in these oral birth control pills and their generic equivalents. Drospirenone can increase blood potassium levels, causing a condition known as hyperkalemia, which is known to cause heart problems and other issues.

The federal Yasmin and Yaz litigation has been consolidated and centralized for pretrial proceedings as part of an MDL, or multidistrict litigation, in the U.S. District Court for the Southern District of Illinois. In addition, a number of cases are consolidated at the state court level in New Jersey and Pennsylvania.

In October 2010, a Case Management Order was established in the federal MDL, scheduling three bellwether trials, which are typically used to help the parties gauge the strengths or weaknesses of their case and facilitate a potential Yaz settlement.

The first trial in the federal MDL is scheduled to begin in federal court on September 12, 2011, involving a Yaz pulmonary embolism lawsuit. The second trial, which will involve a Yaz gallbladder lawsuit, has been set for trial in federal court on January 9, 2012. The third trial involving a venus thromboembolism, such as a deep vein thrombosis from Yaz, will begin on April 2, 2012.

As Yasmin and Yaz lawyers continue to review and file additional cases, some estimates suggest that the total number of lawsuits filed may eventually exceed 25,000.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

After a growing body of evidence has linked use of the Depo-Provera birth control shot to an increased risk of brain tumors, thousands of women nationwide are seeking information on how to sign up for the Depo-Provera lawsuit.
As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase.
A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates.